Jane Buchan
CIK: 0001342502
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMMX
Immix Biopharma, Inc.
Director
Discretionary Trading P&L
Holdings
About BUCHAN JANE
BUCHAN JANE (SEC CIK 0001342502) files insider reports with the SEC as Director of Immix Biopharma, Inc. (IMMX).
Signal8 holds 2 ownership filings by BUCHAN JANE, all Form 4s, filed between Jun 23, 2025 and May 29, 2026. Those filings report 2 transactions, from Jun 20, 2025 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BUCHAN JANE's filings is in LOS ANGELES, CA.
Recent filings by BUCHAN JANE
Other insiders filing for Immix Biopharma, Inc. (IMMX)
- Adams Helen C., Director
- Ng Carey, Director
- Marquet Magda, Director
- Morris Gabriel S, CFO, President
- CHANG NANCY T, Director
- Rachman Ilya M, CEO and Chairman